Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 15/20 | 0.38 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.33 |
| ▸ | FEN1 | P39748 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL783001 | 0.85 | ALDH1A1 (0.45) | PDK2DHFRALOX5APFEN1ADORA3 | |
| SCHEMBL30595509 | 0.82 | PDK2 (0.46) | PDK2SLC6A2SLC6A4 | |
| SCHEMBL27864761 | 0.81 | LPL (0.44) | PDK2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2965864 | 0.80 | PDK2 (0.43) | PDK2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2961760 | 0.80 | PDK2 (0.45) | PDK2SLC6A2SLC6A4 | |
| SCHEMBL21588650 | 0.80 | ALDH1A1 (0.40) | PDK2DHFRALOX5APFEN1ADORA3 | |
| SCHEMBL1649136 | 0.80 | PDK2 (0.47) | PDK2 | |
| SCHEMBL18419419 | 0.79 | PDK2 (0.39) | PDK2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL15405826 | 0.79 | PDK2 (0.38) | PDK2DHFRALOX5APFEN1 | |
| SCHEMBL15946066 | 0.79 | PDK2 (0.47) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220158095-A1 | Compound, Organic Electroluminescent Device Containing Same and Application Thereof | BEIJING ETERNAL MAT TECH CO LTD (CN) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220158095-A1 | Compound, Organic Electroluminescent Device Containing Same and Application Thereof | OR10J3, PIEZO1, TRPM8 | PDK2 942/4885DHFR 1204/4885ALOX5AP 2195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.